carbamazepine
Generic: carbamazepine
Labeler: chartwell governmental & specialty rx, llc.Drug Facts
Product Profile
Brand Name
carbamazepine
Generic Name
carbamazepine
Labeler
chartwell governmental & specialty rx, llc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
carbamazepine 200 mg/10mL
Manufacturer
Identifiers & Regulatory
Product NDC
68999-867
Product ID
68999-867_41dd08a0-b89b-6ad3-e063-6394a90afdc6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075714
Listing Expiration
2026-12-31
Marketing Start
2002-06-05
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68999867
Hyphenated Format
68999-867
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carbamazepine (source: ndc)
Generic Name
carbamazepine (source: ndc)
Application Number
ANDA075714 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/10mL
Packaging
- 2 TRAY in 1 BOX (68999-867-24) / 10 CUP in 1 TRAY / 10 mL in 1 CUP (68999-867-59)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "41dd08a0-b89b-6ad3-e063-6394a90afdc6", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["308976"], "spl_set_id": ["35298eaf-3478-4dfb-a629-298dd52713f0"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Chartwell Governmental & Specialty RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 BOX (68999-867-24) / 10 CUP in 1 TRAY / 10 mL in 1 CUP (68999-867-59)", "package_ndc": "68999-867-24", "marketing_start_date": "20251015"}], "brand_name": "Carbamazepine", "product_id": "68999-867_41dd08a0-b89b-6ad3-e063-6394a90afdc6", "dosage_form": "SUSPENSION", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "68999-867", "generic_name": "Carbamazepine", "labeler_name": "Chartwell Governmental & Specialty RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/10mL"}], "application_number": "ANDA075714", "marketing_category": "ANDA", "marketing_start_date": "20020605", "listing_expiration_date": "20261231"}